UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.864

Sortiert nach

Sclerostin antibody treatment enhances metaphyseal bone healing in rats

Journal of bone and mineral research, 2010-11, Vol.25 (11), p.2412-2418

2010

Volltextzugriff (PDF)

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

Journal of bone and mineral research, 2008-06, Vol.23 (6), p.860-869

2008

Volltextzugriff (PDF)

Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis

Bone (New York, N.Y.), 2015-07, Vol.76, p.141-148

2015

Volltextzugriff (PDF)

Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis

Annals of the rheumatic diseases, 2013-10, Vol.72 (10), p.1732-1736

2013

Volltextzugriff (PDF)

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

Bone (New York, N.Y.), 2006-10, Vol.39 (4), p.754-766

2006

Volltextzugriff (PDF)

Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation

Nature genetics, 2005-09, Vol.37 (9), p.945-952

2005

Volltextzugriff (PDF)

Projections from the Rostral Zona Incerta to the Thalamic Paraventricular Nucleus Mediate Nociceptive Neurotransmission in Mice

Metabolites, 2023-02, Vol.13 (2), p.226

2023

Volltextzugriff (PDF)

Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases

Endocrine reviews, 2012-10, Vol.33 (5), p.747-783

2012

Volltextzugriff (PDF)

Novel actions of sclerostin on bone

Journal of molecular endocrinology, 2019-02, Vol.62 (2), p.R167-R185

2019

Volltextzugriff (PDF)

Effects of sclerostin antibodies in animal models of osteoporosis

Bone (New York, N.Y.), 2017-03, Vol.96, p.63-75

2017

Volltextzugriff (PDF)

Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis

Proceedings of the National Academy of Sciences - PNAS, 2007-06, Vol.104 (25), p.10619-10624

2007

Volltextzugriff (PDF)

Tissue‐Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody

Journal of bone and mineral research, 2014-06, Vol.29 (6), p.1424-1430

2014

Volltextzugriff (PDF)

Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling

Bone (New York, N.Y.), 2015-02, Vol.71, p.63-75

2015

Volltextzugriff (PDF)

Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts

Journal of bone and mineral research, 2017-05, Vol.32 (5), p.892-901

2017

Volltextzugriff (PDF)

Nature-based solutions to mitigate early marsh-edge erosion in a coastal wetland

Ecological engineering, 2024-01, Vol.198, p.107133, Article 107133

2024

Volltextzugriff (PDF)

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair

Nature communications, 2016-05, Vol.7 (1), p.11505-11505, Article 11505

2016

Volltextzugriff (PDF)

Effects of plastic contamination on carbon fluxes in a subtropical coastal wetland of East China

Journal of environmental management, 2023-11, Vol.345, p.118654-118654, Article 118654

2023

Volltextzugriff (PDF)

Dike risk evaluation incorporating the contribution of coastal wetlands: A case study on Chongming Island, China

Ocean & coastal management, 2023-11, Vol.245, p.106874, Article 106874

2023

Volltextzugriff (PDF)

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Journal of bone and mineral research, 2009-04, Vol.24 (4), p.578-588

2009

Volltextzugriff (PDF)

Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap–/– Mice, a Model of Recessive Osteogenesis Imperfecta

Journal of bone and mineral research, 2016-05, Vol.31 (5), p.1030-1040

2016

Volltextzugriff (PDF)

Projections from anteromedial thalamus nucleus to the midcingulate cortex mediate pain and anxiety-like behaviors in mice

Neurochemistry international, 2023-12, Vol.171, p.105640-105640, Article 105640

2023

Volltextzugriff (PDF)

Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading

Journal of bone and mineral research, 2013-04, Vol.28 (4), p.865-874

2013

Volltextzugriff (PDF)

Retention of osteocytic micromorphology by sclerostin antibody in a concurrent ovariectomy and functional disuse model

Annals of the New York Academy of Sciences, 2019-04, Vol.1442 (1), p.91-103

2019

Volltextzugriff (PDF)

Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model

Bone (New York, N.Y.), 2011-02, Vol.48 (2), p.197-201

2011

Volltextzugriff (PDF)

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Journal of bone and mineral research, 2010-12, Vol.25 (12), p.2647-2656

2010

Volltextzugriff (PDF)

1 – 25 von 1.864

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.456)
Mit Volltextzugriff
(1.658)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.110)
Life Sciences & Biomedicine
(708)
Humans
(398)
Physical Sciences
(287)
Animals
(255)
Male
(252)
Female
(240)
Technology
(215)
Chemistry
(152)
Middle Aged
(127)
Engineering
(124)
Adult
(123)
Physics
(104)
Aged
(97)
Mice
(93)
Materials Science
(91)
Biological And Medical Sciences
(90)
Rats
(90)
Science & Technology - Other Topics
(82)
Oncology
(79)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Bone And Mineral Research
(27)
中华医学杂志
(25)
Scientific Reports
(21)
Bone
(20)
Chinese Physics C
(20)
Chinese Physics Letters
(19)
Bone And Mineral
(17)
Zhong Hua Yi Xue Za Zhi
(16)
Aquaculture
(15)
Applied Mechanics And Materials
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Sclerostin antibody treatment enhances metaphyseal bone healing in rats

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis

Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation

Projections from the Rostral Zona Incerta to the Thalamic Paraventricular Nucleus Mediate Nociceptive Neurotransmission in Mice

Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases

Novel actions of sclerostin on bone

Effects of sclerostin antibodies in animal models of osteoporosis

Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis

Tissue‐Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody

Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling

Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts

Nature-based solutions to mitigate early marsh-edge erosion in a coastal wetland

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair

Effects of plastic contamination on carbon fluxes in a subtropical coastal wetland of East China

Dike risk evaluation incorporating the contribution of coastal wetlands: A case study on Chongming Island, China

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap–/– Mice, a Model of Recessive Osteogenesis Imperfecta

Projections from anteromedial thalamus nucleus to the midcingulate cortex mediate pain and anxiety-like behaviors in mice

Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading

Retention of osteocytic micromorphology by sclerostin antibody in a concurrent ovariectomy and functional disuse model

Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Suchergebnisse filtern